Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ...
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ...
Stay updated with breaking news from Stephen Yoder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ...
By Adriano Marchese Pieris Pharmaceuticals shares were halted in premarket trading after its partner AstraZeneca decided to discontinue and cease dosing in...
BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology
FinancialContent fully hosted finance channel
Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call.